GLP-1 medications are not recommended during pregnancy or breastfeeding, and some (like semaglutide) should be discontinued at least 2 months before a planned pregnancy
Although obesity, particularly central adiposity, often coexists with PCOS and is associated with a higher risk of insulin resistance, metabolic syndrome, and type 2 diabetes, lean individuals with PCOS and a normal body mass index also have an increased risk of insulin resistance and cardiometabolic disease
Aggregates, peptide-related impurities, contaminants and formulation components may alter immune recognition
The online pharmacies segment accounted for the largest share of the global market in 2024 due to its unparalleled convenience, allowing patients to order their medications from the comfort of their homes
Rights and permissions About this article Cite this article Halpin, L., Northrop, N